A Skin and Synovial Tissue Assessment of Overlapping Genes and Their Response After 3 Months Treatment With Apremilast in Patients With Psoriatic Arthritis
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriatic arthritis
- Focus Pharmacodynamics; Pharmacogenomic
- 20 Oct 2016 Planned End Date changed from 1 Oct 2017 to 1 Oct 2016.
- 20 Oct 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2016.
- 20 Oct 2016 Status changed from recruiting to withdrawn prior to enrolment.